|
CHD9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.90580000000362E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.573200E-04 |
| Normal-vs-Stage2 |
3.100900E-03 |
| Normal-vs-Stage3 |
2.44839999999913E-05 |
| Normal-vs-Stage4 |
1.52629999999876E-05 |
| Stage1-vs-Stage2 |
7.624200E-01 |
| Stage1-vs-Stage3 |
1.715230E-01 |
| Stage1-vs-Stage4 |
4.840400E-02 |
| Stage2-vs-Stage3 |
5.109200E-01 |
| Stage2-vs-Stage4 |
2.468600E-01 |
| Stage3-vs-Stage4 |
5.254800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.59629999999922E-05 |
| Normal-vs-AfricanAmerican |
1.889410E-01 |
| Normal-vs-Asian |
8.810000E-04 |
| Caucasian-vs-AfricanAmerican |
1.822830E-01 |
| Caucasian-vs-Asian |
9.108600E-01 |
| AfricanAmerican-vs-Asian |
2.077200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.64219999949134E-07 |
| Normal-vs-Female |
3.040400E-04 |
| Male-vs-Female |
9.051600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.916980E-03 |
| Normal-vs-Age(41-60Yrs) |
2.776200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.33530000001603E-06 |
| Normal-vs-Age(81-100Yrs) |
5.176800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.701600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.440300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.888230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.917560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.291200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.587200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.305600E-01 |
| Classical-VS-Follicular |
2.138500E-02 |
| Classical-VS-Other |
3.396600E-01 |
| Classical-VS-Normal |
1.119540E-03 |
| Tall-VS-Follicular |
9.755600E-01 |
| Tall-VS-Other |
8.455000E-01 |
| Tall-VS-Normal |
4.238600E-04 |
| Follicular-VS-Other |
8.855800E-01 |
| Follicular-VS-Normal |
5.97219999999288E-05 |
| Other-VS-Normal |
2.961700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12410000000052E-05 |
| Normal-vs-N1 |
1.425080E-04 |
| N0-vs-N1 |
6.931400E-01 |
|
|
